L3VLUP
ProSign in

CBLL in the 13F filings

Ceribell Inc · CUSIP 15678C102

Sector · Medical devices and instrumentsTheme · Healthcare: biopharma and medtech· L3VLUP-definedTheme · Surgical, medical and electromedical devices
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024
Quarter end
30 Jun 2025
the date the book describes
Filed
14 Aug 2025
latest of these filings; the earliest 14 Aug 2025
Managers listing it
1
at least, of 95 tracked, among listed positions
Comparable managers
95
filed both Q1 2025 and Q2 2025; 0 listed it in both
Shares listed
46,533
combined, among listed positions
Reported value
$872k
combined, at the quarter end

Among the 95 comparable managers: 1 buyer (opened or added shares) and 1 seller (trimmed or exited), at least, among listed positions. Their net change in shares was +21,177.

Managers listing CBLL in Q2 2025

Share of 13F value is the position’s reported value over everything the manager reported that quarter. The share change is against Q1 2025, and only where both filings list the position. A rise in value with no rise in shares is the price, not buying.

1 of 1 holder

ActionFiling
PDT Partners LLC46,533$872kunder 0.1%Newnew14 Aug 2025 (the filing on sec.gov)

Largest increases and reductions, by shares

Q1 2025 to Q2 2025, among managers that listed it in both quarters or opened it.

Increases

Reductions

No reduction among listed positions.

New positions and exits

At least these many: a manager is shown exiting only where its own filing shows the position gone.

New (1)

Exited (1)

Ownership over time

Every quarter on file. A quarter-end value moves with the price as well as with the shares held; buyers and sellers count comparable managers, by shares.
2 in Q4 2024 to 1 in Q2 2026

Tracked managers listing it, at least.

01122Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026
the quarter shown share split complete books; unmarked quarters rest on listed positionsClick a quarter to open it.
CBLL by quarter
QuarterHoldersReported valueBuyersSellers
Q4 20242$905k20
Q1 20251$487k11
Q2 20251$872k11
Q3 20251$535k00
Q4 20251$1.2m155
Q1 20261$966k156
Q2 20261$1.0m1210

Compare with…

Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.

CBLL and LLY →CBLL and JNJ →CBLL and VRTX →Choose a stock to compare with CBLL →

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.

Which funds own CBLL, latest filings →Back to the 13F Explorer →